Initial Lantus Dosing for Medication-Naïve Type 2 Diabetes
Start with 10 units of Lantus once daily at the same time each day, administered subcutaneously. This is the FDA-approved and guideline-recommended starting dose for insulin-naïve patients with type 2 diabetes 1.
Dosing Rationale
The 2025 American Diabetes Association Standards of Care explicitly recommend starting basal insulin at 10 units per day OR 0.1-0.2 units/kg per day for patients with type 2 diabetes 2. The FDA label for Lantus confirms this same recommendation: 10 units (or 0.2 units/kg) once daily for patients with type 2 diabetes not currently treated with insulin 1.
For your 60-year-old patient with an A1c of 9.9%, this fixed 10-unit starting dose is appropriate and safe, regardless of whether you calculate it as a flat dose or weight-based (0.1-0.2 units/kg would typically yield 8-16 units for most adults).
Titration Strategy
After initiating at 10 units, increase the dose by 2 units every 3 days until the fasting plasma glucose (FPG) goal is reached without hypoglycemia 2. Set a specific FPG target (typically 80-130 mg/dL or 4.4-7.2 mmol/L for most adults).
The evidence-based titration algorithm from the ADA guidelines is straightforward:
- Increase by 2 units every 3 days based on FPG readings
- Continue titration until FPG goal is achieved
- If hypoglycemia occurs without clear cause, reduce dose by 10-20% 2
Research supports that this conservative approach with systematic titration achieves HbA1c reductions of 1.5-2.5% while minimizing hypoglycemia risk 3, 4.
Important Considerations
Do not start with higher weight-based dosing (0.3-0.4 units/kg) used in some research studies 5. Those doses were studied in patients already on oral medications and aimed for more aggressive glucose targets. Your patient is medication-naïve, making the conservative 10-unit start safer and FDA-recommended.
Administer at the same time daily - timing consistency matters more than whether it's morning or evening 1. Evening/bedtime dosing is traditional for targeting fasting glucose.
Rotate injection sites within the same region (abdomen, thigh, or deltoid) to reduce lipodystrophy risk 1.
Critical Safety Points
- Never administer Lantus intravenously or via insulin pump - subcutaneous only 1
- Never dilute or mix Lantus with other insulins 1
- Prescribe a glucagon emergency kit for severe hypoglycemia 2
- Educate on hypoglycemia recognition and self-monitoring of blood glucose
Follow-Up and Reassessment
Reassess every 3-6 months to avoid therapeutic inertia 2. With an A1c of 9.9%, expect to need ongoing dose increases during titration. Most patients require 40-70 units daily to achieve HbA1c <7%, though individual needs vary 6.
If the patient doesn't reach goal on basal insulin alone (signs of "overbasalization" include high bedtime-to-morning glucose differential or requiring >0.5 units/kg), consider adding a GLP-1 receptor agonist rather than pushing basal insulin higher 2.